Papers
2
Total Citations
17
H-Index
2
About
Chee‐Yin Chai is a dedicated surgical oncologist whose research centers on optimizing surgical outcomes for colorectal cancer, with a particular focus on rectal cancer treatment. Her major contributions lie in evaluating the efficacy and safety of different surgical modalities for total mesorectal excision (TME), including conventional laparoscopic surgery and robotic-assisted surgery. In her most-cited observational study, she systematically compared patho-oncological outcomes across these approaches, providing valuable real-world evidence from a single-center analysis that helps guide clinical decision-making. This work has garnered over 17 citations, reflecting its relevance to surgeons and oncologists seeking to refine minimally invasive techniques. Chai’s research addresses critical questions about the role of neoadjuvant concurrent chemoradiotherapy (CCRT) in conjunction with TME, contributing to the ongoing dialogue on how to balance oncological radicality with surgical precision. Her findings support the growing adoption of advanced surgical platforms while emphasizing the importance of patient selection and standardized protocols. Through her careful, evidence-based approach, Chee‐Yin Chai continues to advance the field of colorectal surgery, offering insights that directly impact patient care and surgical practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2